An anaesthetic halocarbon capture system is provided. The system includes a pressure-intolerant sleeve containing filter material for capturing one or more types of anaesthetic halocarbon prior to supercritical fluid extraction, and a pressure-tolerant housing into which the sleeve can be inserted so as to permit exposure of the sleeve contents to pressures required for supercritical fluid extraction.

A device and a system that delivers continuous positive airway pressure in conjunction with oxygen delivery is disclosed. The system is portable so that patients may be mobile and conveniently travel. Several means are disclosed for integrating oxygen production into a positive airway pressure (PAP) device, including oxygen production machinery entirely integrated into the PAP housing, oxygen production machinery that mates with a PAP device but which may operate independently, and where portions of the oxygen production machinery are located in the PAP housing and other portions (for example, the compressor) are located in a separate module, such as, for example, an AC-to-DC power conversion module.

Oxygen concentrator methods and apparatus estimate sieve bed effective capacity. Estimation applies function(s) to a parameter of a measured pressure-time characteristic of the bed, characteristic of a phase of an adsorption cycle of the concentrator at a predetermined motor speed of its compression system. Estimation may involve operating the concentrator at a predetermined bed pressure and measuring a mass flow of gas entering or exiting the bed, and may use the measured mass flow and one or more functions. Estimation may involve a measured bed exhaust mass flow for a purge phase when bed pressure is regulated to maintain a predetermined target pressure using motor speed adjustment. The estimation may apply exhaust mass flow function(s) to the measured exhaust mass flow. Estimation of the effective capacity may involve applying motor speed function(s) to measured motor speed, such as an adjusted one for regulating canister pressure to achieve a target pressure.

A transportable extracorporeal system includes a housing, a blood flow inlet, a blood flow outlet, a plurality of hollow gas permeable fibers, a gas inlet in fluid connection with inlets of the plurality of hollow gas permeable fibers, a gas outlet in fluid connection with outlets of the plurality of hollow gas permeable fibers, a first moving element, a concentrated oxygen generating device, a second moving element, a hollow transport conduit having a proximal opening and a distal opening and a power source configured to provide power to the first and second moving elements. The plurality of hollow gas permeable fibers comprising a gas transfer membrane. The concentrated oxygen generating device is configured to recycle waste oxygen from the gas transfer membrane to increase throughput and remove, by an adsorption/desorption process, unwanted gasses.

A method for producing valuable organic liquid from a biomass wherein a gas is heated to a predetermined temperature to produce a heated gas. The heated gas is mixed with a biomass to produce an enriched organic vapor and a biomass waste product. The biomass waste product is separated from the enriched organic vapor. The enriched organic vapor is cooled to produce a liquid organic oil and the liquid organic oil is collected. A system for producing the liquid organic oil wherein the system includes a heat source for heating a gas to produce a heated gas and a first separation unit to separate an enriched organic vapor and a biomass waste product. The enriched organic vapor and the biomass waste product are generated from mixing the heated gas and a biomass. The system also includes a wet scrubber for cooling the enriched organic vapor to remove certain compounds from the enriched organic vapor to generate an enriched organic smoke. The organic smoke can be transformed to the liquid organic oil in an electrostatic precipitator.

The present disclosure is directed to systems and methods of providing a mixed-gas inhalant to a patient via a gas recirculation loop. The gas recirculation loop receives a first mixed-gas exhalant having a first carbon dioxide concentration from the patient, one or more carbon dioxide removal devices discharge a second mixed-gas exhalant having a second carbon dioxide concentration that is less than the first carbon dioxide concentration. The second mixed-gas exhalant is combined with a mixed-gas supply to provide a mixed-gas inhalant. The mied-gas supply includes a first gas and a second gas. The mixed-gas supply is pressure and flow controlled to produce a mixed-gas inhalant having a defined composition delivered to the patient at a defined volumetric flow rate. The first gas may include a gas containing oxygen and the second gas may include a gas mixture containing a noble or inert gas and oxygen.

A surgical treatment system for contaminated air streams having particulate contamination, polar contamination and/or nonpolar contamination in the gas or vapor stream. A surgical smoke plume treatment system and method provide or define a multi-stage treatment process that mechanically filters the air stream, followed by nonpolar decontamination and then polar decontamination or treatment. The system may be used stand alone or incorporated and used with other surgical instruments or incorporated into an air handler adapted to decontaminate an air stream. A desiccant may optionally be used to remove water from the air stream.

A passive valve for use as a fixed leak valve. The valve includes a body having an internal chamber, first and second body ports in fluid communication with the chamber with the first port configured for fluid communication with a patient connection and the second body port configured for fluid communication with a ventilator, a body passageway in fluid communication with the chamber and with ambient air exterior of the body, and a check valve seal positioned to seal the body passageway to permit the flow of gas within the chamber through the body passageway to the exterior of the body and to prevent the flow of ambient air exterior of the body through the body passageway into the chamber. In alternative embodiments, the valve is incorporated into the patient connection or constructed as a separate part connectable to the patient connection.

A pressure swing adsorption (PSA) system and methods for controlling each PSA cycle performed by the PSA system to produce oxygen enriched gas during productive portions of a user breathing cycle, and to cease production of oxygen enriched gas during non-productive portions of the user breathing cycle, is provided. The PSA system synchronizes PSA cycle phases including adsorption and desorption phases with a user's individual inhalation and exhalation phases, on a breath by breath basis, such that each PSA cycle can be dynamically varied from a succeeding PSA cycle, in real time in response to variations in the user's breathing cycle. An oxygen delivery device including a breathing cycle sensor provides breathing cycle inputs to a controller for use with at least one algorithm to detect breathing flow phases during each user breath, and to synchronize each PSA cycle to the user's breathing flow phases, on a breath-by-breath basis.

Portable oxygen concentrator elements are described including integrated sensor/accumulator assemblies, new muffler designs, and improved airflow and internal gas connectivity. The result of the elements is an extremely compact, light reliable portable oxygen concentrator that is easy to assemble and relatively inexpensive.